BAUSCH HEALTH COMPANIES INC/ CA0717341071 /
| 5/10/2021 10:00:00 PM | Chg. -0.80 | Volume | Bid10:29:59 PM | Ask10:29:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 33.28CAD | -2.35% | 468,424 Turnover: 15.54 mill. |
33.20Bid Size: 700 | 33.35Ask Size: 800 | 12.55 bill.CAD | - | - |
GlobeNewswire
5/10
Clearside Biomedical Announces Multiple Poster Presentations at the Association for Research in Visi...
GlobeNewswire
5/4
Nicox’s Licensee Bausch + Lomb Launches VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%...
GlobeNewswire
5/3
Clearside Biomedical Announces Resubmission of New Drug Application for XIPERE™ for Treatment of Mac...
GlobeNewswire
4/16
BAUSCH HEALTH ANNOUNCES VYZULTA® (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION), 0.024%, IS NOW APPROVED...
GlobeNewswire
3/25
EyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business Update
GlobeNewswire
2/9
Bausch Health Announces Vyzulta® (latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved...
GlobeNewswire
2/8
Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Socie...
GlobeNewswire
11/16/2020
Clearside Biomedical Announces Data Presentations at the American Academy Ophthalmology (AAO) 2020 A...
GlobeNewswire
11/12/2020
Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update
GlobeNewswire
10/13/2020
Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential L...
GlobeNewswire
9/24/2020
BAUSCH HEALTH ANNOUNCES VYZULTA® (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION), 0.024%, IS NOW APPROVED...
GlobeNewswire
9/23/2020
Clearside Biomedical Announces Clinical Data Presentations at The Retina Society 2020 and Publicatio...
GlobeNewswire
9/17/2020
InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strateg...
GlobeNewswire
9/3/2020
Sol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobri...
GlobeNewswire
8/10/2020
Clearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update
GlobeNewswire
8/6/2020
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update